TGTGInsighttelegram intelligenceLIVE / telegram public index
← python-telegram-bot

TGINSIGHT SIMILAR POSTS

Find similar content

Source channel @pythontelegrambotchannel · Post #89 · Oct 7

The v13 release is not just a release either, it is also our official announcement of participation in the annual #hacktoberfest. 💻🥨 We know that we're a few days late to the party, but v13 had to get ready before. 😉 This year, the fest is opt-in for projects and we definitely want to opt into taking part in this great event! If you ever thought about starting coding or giving back to your favourite open source repositories, now is the time! Head over to the hacktoberfest website to learn more about it. We already prepared some issues on our repositories and aim towards opening more issues for starters, but feel free to begin a hunt for improvements and fixes by yourself!

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选
Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment